Ohio Clinical Trials

Recruiting studies in Ohio

• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06095583Limited-stage Small Cell Lung Cancer (LS-SCLC)Toledo, OH
• A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
  NCT07194265Severe Aortic StenosisCincinnati, OH
• Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation
  NCT06885554Adjustment DisordersWright-Patterson Air Force Base, OH
• Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
  NCT07214311Prosthetic-joint InfectionCincinnati, OH
• A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
  NCT05519085Relapsed or Refractory Multiple MyelomaCincinnati, OH
• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
  NCT07003425Atopic DermatitisBoardman, OH
• Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
  NCT06172296Ganglioneuroblastoma, NodularAkron, OH
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723Chronic Kidney Disease and HypertensionCanton, OH
• A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
  NCT05645107HypogammaglobulinemiaCanton, OH
• Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
  NCT07192432HER2 Expressing Solid TumorsCleveland, OH
• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
  NCT06623422Carcinoma, Non-Small-Cell LungCincinnati, OH
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
  NCT06625060Episodic MigraineCincinnati, OH

See all 3,003 recruiting Ohio trials →

Clinical trials by Ohio metro

• Columbus
• Cleveland
• Cincinnati
• Dayton

Popular conditions in Ohio

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Ohio?

Corterve aggregates actively recruiting clinical trials with sites in Ohio from the public ClinicalTrials.gov registry. Browse the studies on this page or take a free health assessment to find trials you may qualify for.

Are clinical trials in Ohio free to join?

Study participation is typically free — sponsors cover the investigational treatment and study-related visits, and many studies compensate participants for time and travel. Details vary by study.

What kinds of clinical trials are available in Ohio?

Ohio research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.